Amorfix announces vCJD blood test breakthrough
Canada's Amorfix Life Sciences has announced a breakthrough in the development of a blood test for variant Creutzfeldt-Jakob disease (vCJD). The Toronto-based specialist in diagnostics, theranostics and therapies for a range of neurodegenerative diseases has reported 100% sensitivity and 100% specificity for its EP-vCJD test in a second blinded trial of human blood samples, in collaboration with the UK's National Institute for Biological Standards and Control (NIBSC).
The successful completion of testing with both fresh and frozen human plasma, as validated by the NIBSC, paves the way for large-scale testing of the diagnostic.
EMEA about to open doors to Advanced Therapy product applications
The European Medicines Agency (the EMEA) is readying itself to deal with Advanced Therapy Medicinal Products as of the beginning of next year.
HistoRx names vice-president of new diagnostics marketing division
HistoRx appoints Kathleen Adams vice-president of diagnostics marketing. Ms Adams joins from Quest Diagnostics.
Vicor Technologies names vice-president and accounting officer
Thomas Bohannon is named vice-president and chief accounting officer for Vicor Technologies, an early-stage biotechnology company that develops software for diagnostic purposes.
"Wholehearted" industry support for Carter Review – with caveats
Transforming NHS pathology services will improve quality, safety and efficiency in diagnostic tests." So said the UK's Department of Health of the publication today, as Clinica's daily service went to press, of the long-awaited review into NHS Pathology Services, the so-called Carter Review.
Keeping Europe at the forefront of innovation: pitfalls to avoid
Europe is renowned for growing ideas that result in innovative medtech products, even if US investors and medtech companies then buy them up and benefit. Can this inventive streak be maintained, Amanda Maxwell asked medtech regulatory expert-turned-investor, Thierry Chignon.
Rock-it science: research highlights dangers of heavy metal
Since the genre was born with the release of Black Sabbath's eponymous album in 1970, many people have claimed that heavy metal is bad for your health.
Clinica Delivers:
- Daily email of hand picked industry critical news and developments
- 25 feature-packed issues a year in print or as PDF - both with FREE online access
- Exclusive features such as Medtech ventures and New Stock Tracker
- A fully-searchable archive of issues and articles dating back to 1995.
The NEW daily market
intelligence service for the international diagnostics
industry – the must-have resource for professionals
in the in-vitro diagnostics
sector.
